Global Infertility Drugs Market Report 2022: Factors Increasing Infertility Cases in Men and Women Drive Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Infertility Drugs Market Size, Industry Share and Trend Analysis Report by End User, by Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, and Online Pharmacy), by Class of medicine, by regional perspective and forecast, 2022 – The 2028 report” has been added to ResearchAndMarkets.com offer.

The global market size of infertility drugs is expected to reach USD 4.8 billion by 2028, increasing with a market growth of 6.2% CAGR during the forecast period.

Market growth factors

Factors that increase cases of infertility in men and women

The rising prevalence of infertility or the difficulty of carrying a baby to term around the world is what fuels the infertility drug market. Infertility can be caused by a number of diseases that affect both men and women, including diabetes, cystic fibrosis, testicular failure, hormonal imbalances, menopausal disorders, urinary tract infections, pelvic inflammatory disease (PID), endometriosis, ovarian cysts, among others. others . Smoking, using anabolic steroids, stress, obesity and other poor lifestyle choices are to blame for the increase in these problems, which also contributes to the need for infertility medication.

Increasing research and development for better treatment

Due to increasing research studies and development of more efficient treatments to induce conception and deliver live babies, the market for infertility drugs is expected to expand significantly. For example, a group of researchers at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) found in 2014 that women treated with letrozole have higher rates of ovulation and live births than the women treated with the standard medication, Clomiphene.

End User Outlook

Based on the end user, the infertility drug market is divided into men and women. The female segment led the market with the highest market revenue share in 2021. This dominance could be related to the wide accessibility of female infertility drugs. In the United States, 11% of women and 9% of men of reproductive age are infertile, according to the US Department of Health and Human Services.

Distribution Channel Perspectives

Based on the distribution channel, the infertility drug market is divided into hospital pharmacy, specialty and retail pharmacy, and online pharmacy. Online Pharmacy generated significant revenue share during 2021 in the market. The emergence of online clinical chains, which provide patients with scheduled medication deliveries and promote patient discretion due to the social stigma associated with the disease, can be credited with the rise of the segment.

Drug Class Perspective

Based on drug class, the infertility drug market is classified into gonadotropins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), dopamine agonists, and others. The gonadotropins segment accounted for the largest share of market revenue in 2021. This can be attributed to the high cost of products and the effect of greater effectiveness on increased consumption. Gonal-F, Follitismo, Menopur and Bravelle gonadotropins are some of the most frequently prescribed for the treatment of infertility in patients.

Study scope

By end user

By Distribution Channel

  • Hospital Pharmacy

  • Specialty and retail pharmacy

  • online pharmacy

By drug class

  • gonadotropins

  • Aromatase Inhibitors

  • Selective Estrogen Receptor Modulators (SERMs)

  • Dopamine Agonists

  • Others

Main market players

List of companies profiled in the report:

  • Abbott Laboratories

  • Bayer AG

  • Novartis AG

  • Merck & Co., Inc.

  • Pfizer, Inc.

  • Teva Pharmaceutical Industries Ltd.

  • Sanofi SA

  • Ferring Holdings SA

  • Organon & Co.

  • Pharmaceutical Humanity Ltd.

Main topics covered:

Chapter 1. Market Scope and Methodology

Chapter 2. Market overview

Chapter 3. Global Infertility Drugs Market by End User

Chapter 4. Global Infertility Drugs Market by Distribution Channel

Chapter 5. Global Infertility Drug Market by Drug Class

Chapter 6. Global Infertility Drugs Market by Region

Chapter 7. Company Profiles

For more information on this report, please visit https://www.researchandmarkets.com/r/j24u5p

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key sectors, top companies, new products and the latest trends.

Global Infertility Drugs Market Report 2022: Factors Increasing Infertility Cases in Men and Women Drive Growth – ResearchAndMarkets.com

Leave a Reply

Your email address will not be published.

Scroll to top